Examination of the effect of continuous intake of test foods on immune function.
- Conditions
- Healthy adults
- Registration Number
- JPRN-UMIN000042449
- Lead Sponsor
- IMEQRD Co., Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Not provided
1.Those who are currently under continuous treatment with drugs. (Abortive use is acceptable.) 2. Those who are on a diet or exercise therapy under the supervision of a doctor. 3. Those who have a current or history of serious illness. 4. Those with atopic dermatitis, allergic rhinitis (seasonal / perennial), bronchial asthma, chronic bronchitis 5. Those who are currently using quasi-drugs, foods for specified health uses, health foods and supplements. Those who can quit during the test period after obtaining consent are allowed to participate. 6. Those who regularly intake foods containing lactic acid bacteria or bifidobacterium. 7. Those who have been vaccinated with influenza vaccine within 1 month before the pre-intake test, or who will be vaccinated during the test period 8. Those who have a past and current medical history of drug or food allergy. 9. Those who work in shifts, such as those who work night shifts 10. Those who consume alcohol excessively (alcohol equivalent 60g or more / day) 11. Those who have excessive smoking habits (21 or more cigarettes / day) 12. Those who are planning to travel abroad during the test period 13. Those who wish to become pregnant, breastfeeding, or during the test period 14. Those who have participated in other clinical trials within one month before obtaining consent, or those who plan to participate during the test period 15. Those who are judged by the investigator or coordinator to be unsuitable for participating in this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Inflammatory markers, body temperature measurement, questionnaire
- Secondary Outcome Measures
Name Time Method